Shares of CARSGEN-B Surge Over 5% Following EHA Poster Presentations for CT0596 and CT1190B

Stock News06-15

Shares of CARSGEN-B (ASX: 02171) have risen by more than 5%. At the time of writing, the stock is up 4.86% to HK$15.75, with a trading turnover of HK$86.18 million.

The upward movement follows a company announcement on June 15th. Research findings for CT0596, a universal CAR-T cell product targeting BCMA for treating relapsed/refractory multiple myeloma (R/R MM) and plasma cell leukemia (PCL), along with results for CT1190B, a universal CAR-T cell product targeting CD19/CD20 for treating relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL), have been presented as poster displays at the 2026 European Hematology Association (EHA) Annual Meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119112920?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 13:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119112920","market":"nz","top_or_hot":-1,"title":"Shares of CARSGEN-B Surge Over 5% Following EHA Poster Presentations for CT0596 and CT1190B","media":"Stock News","content":"<p>Shares of <b>CARSGEN-B</b> (<b>ASX: 02171</b>) have risen by more than 5%. At the time of writing, the stock is up 4.86% to HK$15.75, with a trading turnover of HK$86.18 million.<br><br>The upward movement follows a company announcement on June 15th. Research findings for CT0596, a universal CAR-T cell product targeting BCMA for treating relapsed/refractory multiple myeloma (R/R MM) and plasma cell leukemia (PCL), along with results for CT1190B, a universal CAR-T cell product targeting CD19/CD20 for treating relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL), have been presented as poster displays at the 2026 European Hematology Association (EHA) Annual Meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shares of CARSGEN-B Surge Over 5% Following EHA Poster Presentations for CT0596 and CT1190B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShares of CARSGEN-B Surge Over 5% Following EHA Poster Presentations for CT0596 and CT1190B\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-15 13:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>CARSGEN-B</b> (<b>ASX: 02171</b>) have risen by more than 5%. At the time of writing, the stock is up 4.86% to HK$15.75, with a trading turnover of HK$86.18 million.<br><br>The upward movement follows a company announcement on June 15th. Research findings for CT0596, a universal CAR-T cell product targeting BCMA for treating relapsed/refractory multiple myeloma (R/R MM) and plasma cell leukemia (PCL), along with results for CT1190B, a universal CAR-T cell product targeting CD19/CD20 for treating relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL), have been presented as poster displays at the 2026 European Hematology Association (EHA) Annual Meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1119112920","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119112920","pubTimestamp":1781502861,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of CARSGEN-B (ASX: 02171) have risen by more than 5%. At the time of writing, the stock is up 4.86% to HK$15.75, with a trading turnover of HK$86.18 million.The upward movement follows a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","BK4585":"ETF&股票定投概念","BK1587":"次新股","BK1574":"生物医药B类股","BK1585":"昨日强势股","02171":"科济药业-B","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股"},"translate_title":"CT0596和CT1190B的EHA海报展示后，科济源-B股价飙升超过5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"02171":1},"content_text":"Shares of CARSGEN-B (ASX: 02171) have risen by more than 5%. At the time of writing, the stock is up 4.86% to HK$15.75, with a trading turnover of HK$86.18 million.The upward movement follows a company announcement on June 15th. Research findings for CT0596, a universal CAR-T cell product targeting BCMA for treating relapsed/refractory multiple myeloma (R/R MM) and plasma cell leukemia (PCL), along with results for CT1190B, a universal CAR-T cell product targeting CD19/CD20 for treating relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL), have been presented as poster displays at the 2026 European Hematology Association (EHA) Annual Meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119112920","isCrawlerRequest":true}